US Bancorp’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$192K Buy
2,303
+63
+3% +$4.99K ﹤0.01% 2046
2025
Q4
$174K Buy
2,240
+375
+20% +$25.3K ﹤0.01% 2104
2025
Q3
$106K Buy
1,865
+166
+10% +$7.49K ﹤0.01% 2325
2025
Q2
$74.1K Buy
1,699
+575
+51% +$19.8K ﹤0.01% 2588
2025
Q1
$30.8K Sell
1,124
-54
-5% -$1.97K ﹤0.01% 2980
2024
Q4
$47.4K Sell
1,178
-287
-20% -$13K ﹤0.01% 2765
2024
Q3
$69.3K Sell
1,465
-651
-31% -$28.7K ﹤0.01% 2574
2024
Q2
$63.2K Sell
2,116
-949
-31% -$32.9K ﹤0.01% 2545
2024
Q1
$123K Buy
3,065
+72
+2% +$2.58K ﹤0.01% 2249
2023
Q4
$76.2K Buy
2,993
+2,698
+915% +$48.2K ﹤0.01% 2457
2023
Q3
$4.1K Sell
295
-23
-7% -$462 ﹤0.01% 3493
2023
Q2
$7.31K Buy
318
+23
+8% +$659 ﹤0.01% 3370
2023
Q1
$8.74K Hold
295
﹤0.01% 3333
2022
Q4
$7.36K Buy
+295
New +$7.87K ﹤0.01% 3389
2022
Q2
Sell
-204
Closed -$9K 4148
2022
Q1
$9K Buy
+204
New +$8.62K ﹤0.01% 3412

Other funds holding KYMR